Does Mao Inhibitors Interact with Lumateperone?
Mao Inhibitors and Lumateperone have a moderate drug interaction according to U.S. FDA drug labeling data. Increases lumateperone exposure, which may increase risk of adverse reactions. Reduce CAPLYTA dosage to 10.5 mg once daily. The mechanism involves cyp3a4 inhibition increases lumateperone exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Lumateperone Class
- Atypical Antipsychotic
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Mao Inhibitors and Lumateperone occurs because cyp3a4 inhibition increases lumateperone exposure. Clinically, this means increases lumateperone exposure, which may increase risk of adverse reactions. reduce caplyta dosage to 10.5 mg once daily. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Mao Inhibitors and your doctor is considering prescribing Lumateperone (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider